Tina Tai
Co-Head of Patent
King & Wood Mallesons
Personal Profile
Ms. Tai specializes in patent practice in the fields of chemistry and biopharmaceuticals. She represents internationally renowned multinational corporations in patent invalidation, administrative litigation and
patent infringement cases, while also providing clients with comprehensive legal services encompassing patent applications, consultation, invalidation proceedings and administrative litigation.
Ms. TAI is one of the most influential figures in IP law in the pharmaceutical and healthcare sectors, and has represented many influential cases including the Viagra® (Sildenafil) and Lipitor® (Atrovastatin) for
Pfizer, Brillinta® (Ticagrelor) for AstraZeneca, Xarelto® (Rivaroxaban) for Bayer, Actemra® (Tocilizumab) and Xofluza® (baloxavir marboxil) for Roche/Chugai, Victoza® (Liraglutide) and Wegovy® (semaglutide) for Novo Nordisk, Entresto® (Valsartan Sacubitril) and Revolade® (Eltrombopag) for Novartis, in the patent invalidation and infringement litigations.
